Training courses & Webinars:
Industry

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Next events:

  • 15-16 Oct 2025 Advanced Veterinary Pharmacovigilance
  • 4 Nov 2025 A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products

See all 19 courses

Next events:

  • 26 Nov 2025 US FDA - Understanding Key Factors When Working with the FDA
  • 12 May 2026 US FDA - Understanding Key Factors When Working with the FDA

See all 3 courses

Next events:

  • 18-19 Jun 2026 Cosmetovigilance
  • 8-9 Dec 2026 Cosmetovigilance

See all 2 courses

Next events:

  • 15-16 Oct 2025 Medical Device Studies: Clinical Evidence
  • 20-21 Oct 2025 Sterilization of Medical Devices

See all 60 courses

Next events:

  • 30 Sep-1 Oct 2025 Biosimilars
  • 30 Sep 2025 Effective Technical Writing & Editing

See all 151 courses

I particularly liked working groups. Very good!

Manon Schönholzer, Drug Safety officer, CIS Bio international

Very good. I was expected to improve my knowledge and get some tips and I did it.

Manon Schönholzer, Drug Safety officer, CIS Bio international

It was a very very informative webinar which I certainly will recommend to others

Nanna Sommer, Clinical Trial Assistant, Minervax ApS

Good presenter.

Hanne Storgaard, Clinical Quality Operations Lead- Suppliers, MSD Denmark

The overall content was strong and informative and I believe there was a good mix of discussions, workshops and information. I wanted to deepen my understanding of clinical trial monitoring, particularly the common pitfalls and how to manage them effectively and how to best monitor online/off-site. I believe I’ve learned several valuable methods for identifying and evaluating issues when something goes wrong in a clinical study. I found the sections on risk-based monitoring approaches very insightful and applicable to my work. I also gained insights into ensuring patient safety and maintaining data integrity, as well as the principles of risk-based monitoring. The session on root cause analysis was especially valuable, and I plan to implement this approach in my own clinical study. Overall, I feel that I’ve achieved the goals I set out for this course.

Isabella Åström, Clinical Research Associate, Atos Medical

Overall very good.

William Hensler, Principal, Alantra BioPharma

Group tasks were good, as the interactive parts put theory into practice. Language, speed, flow, and overall presentation was good and easy to follow. Absolutely worth while as an intro to writing of SOPs.

Thomas Bidstrup, Clinical Research Specialist, Ambu A/S

The programme was well-structured and informative. The session provided practical guidance on structuring SOPs, using clear and concise language, and tailoring content to the intended audience. The real-world examples and actionable tips were especially valuable, and I now feel more confident in my ability to revise or create SOPs that align with current standards and expectations. The speaker was very knowledgeable and engaging throughout. Her expertise in SOP writing was clear, and she communicated complex ideas in a straightforward and easy-to-understand way. I particularly appreciated the practical examples and real-life scenarios shared, which made the content more relatable and actionable. She also encouraged questions and interaction, creating a welcoming and supportive learning atmosphere. Overall, her delivery significantly enhanced the quality and value of the training. It struck a good balance between theory and actionable advice, which made it easy to understand and apply.

In summary, the webinar was a valuable learning experience that provided useful tools and insights for writing effective SOPs.

Amalia Neophytou, Trainer Analyst, Remedica Ltd

I hoped to achieve a full picture of APIs for my new job and yes I accomplished it. A lot of information..

Marie Lucchini, Regulatory affairs Supervisor, Actylis

I have accomplished a better understanding of API's after the two day webinar. Very good webinar which covers a good range of content, a little dense, so will need to refer back to it at some stage. Speakers were nice and accommodating. They clearly have a good understanding of the content they are presenting.

Stephany Banglayan, Research and Development Analyst, Xeolas Pharmaceuticals